Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-214635
Abstract: I was pleased to read the article by Kaneko and colleagues1 on the efficacy and safety of tocilizumab in patients with adult-onset Still’s disease, because the current information on its biologic efficacy has been mainly… read more here.
Keywords: onset still; adult onset; disease refractory; tocilizumab patients ... See more keywords